Post by Ypsomed AG
40,508 followers
Q1 FY2026/27 Update from Ypsomed š¢. CEO Simon Michel provides an update on Ypsomed's first quarter of fiscal year 2026/27. Thanks to new customer projects spanning many therapeutic areas, international recognition for its innovation, and the planned expansion of manufacturing capacity, the company enjoyed a strong start to the new fiscal year š. Read more š https://lnkd.in/ed_icJbq Ā #ypsomed #MedTech #innovation #FY2627 #InvestorUpdate
Video Content